Step down of inhaler therapy in well controlled asthmatics with ICS/LABA, Symbicort Turbuhaler.
Phase of Trial: Phase IV
Latest Information Update: 12 May 2017
At a glance
- Drugs Budesonide (Primary) ; Budesonide/formoterol (Primary)
- Indications Asthma
- Focus Therapeutic Use
- 09 May 2017 Planned End Date changed from 1 Sep 2012 to 30 Sep 2014.
- 09 May 2017 Status changed from recruiting to discontinued.
- 17 Jun 2011 New trial record